Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

GHDX - Genomic Health Inc.

Previous close
63.44
63.440   100.000%

Share volume: 0
Last Updated: Thu 07 Nov 2019 10:00:00 PM CET
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
53%
Profitability 75%
Dept financing 25%
Liquidity 17%
Performance 46%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$63.44
P/E Ratio 
N/A
DAY RANGE
$63.44 - $63.44
EPS 
$0.00
52 WEEK RANGE
$50.77 - $86.70
52 WEEK CHANGE
-$22.32
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,806,131
AVERAGE 30 VOLUME 
$806,758
Company detail
CEO:
Region: US
Website: http://www.genomichealth.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. Genomic Health was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.

Recent news